 |
  
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
U.S. News HIV Diagnostics: SAMHSA to Purchase $4 Million of OraQuick Rapid HIV Antibody TestsSeptember 3, 2004 OraSure Technologies Inc. has announced that the US Substance Abuse and Mental Health Services Administration will invest $4 million in purchasing its OraQuick Rapid HIV Antibody Tests and confirmatory test services. SAMHSA will deploy these to more than 22,000 substance abuse treatment and prevention sites across the nation. The company expects to begin supplying the products in the fourth quarter of this year and complete shipment by the end of 2005. AIDS Weekly 08.30.04  This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. |
 |
Email
Print-Friendly
Glossary
The Body: About The Body | Contact The Body | Content Policy | Content Providers | Advertise With Us | Site Map
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
The Body is a service of Remedy Health Media, LLC, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
